- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: severe COPD
Total 12445 results
-
VA Office of Research and DevelopmentCompletedHeart Failure | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Sunovion Respiratory Development Inc.Completed
-
Spiration, Inc.Tigermed Consulting Co., Ltd; Olympus CorporationCompletedPulmonary Disease, Chronic Obstructive | EmpyhsemaChina
-
Dimagi Inc.Boston Medical CenterCompletedPulmonary Disease, Chronic Obstructive
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseJapan
-
Actegy Ltd.Completed
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Universitair Ziekenhuis BrusselUnknownCOPD | Severe AsthmaBelgium
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Hospital Son EspasesSpanish Research Center for Respiratory Diseases; Fundación Mutua MadrileñaCompletedChronic Obstructive Pulmonary DiseaseSpain
-
Schön Klinik Berchtesgadener LandResMedCompletedChronic Obstructive Pulmonary Disease SevereGermany
-
Fekri AbrougCompletedCOPD ExacerbationTunisia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCzechia, Hungary
-
University Medical Center GroningenCompletedEmphysema | COPDNetherlands
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownPulmonary Hypertension | COPDChina
-
AstraZenecaTerminatedPulmonary Disease, Chronic ObstructiveUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.Completed
-
Regione VenetoAzienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera di... and other collaboratorsCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
Ache Laboratorios Farmaceuticos S.A.WithdrawnChronic Obstructive Pulmonary Disease | COPD
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
All India Institute of Medical Sciences, New DelhiCompletedPulmonary Disease, Chronic Obstructive | RehabilitationIndia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Cairo UniversityUnknownPulmonary Hypertension | Chronic Obstructive Lung DiseaseEgypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Czech Republic, Germany, Hungary, Poland
-
University of Split, School of MedicineCompletedDisturbed Blood Flow Induces Endothelial Dysfunction in Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseGermany
-
AstraZenecaCompleted